Transplantation of Bone Marrow Cells Reduces Ccl4–Induced Liver Fibrosis in Mice

Hepatology - Tập 40 Số 6 - Trang 1304-1311 - 2004
Isao Sakaida1,2, Shuji Terai1, Naoki Yamamoto1, Koji Aoyama1, Tsuyoshi Ishikawa1, Hiroshi Nishina3, Kiwamu Okita1
1Department of Gastroenterology and Hepatology, School of Medicine, Yamaguchi University, Yamaguchi, Japan
2fax: (81) 836-22-2240
3Department of Physiological Chemistry, Graduate School of Pharmaceutical Science, University of Tokyo, Tokyo, Japan

Tóm tắt

We investigated the effect of bone marrow cell (BMC) transplantation on established liver fibrosis. BMCs of green fluorescent protein (GFP) mice were transplanted into 4–week carbon tetrachloride (CCl4)-treated C57BL6 mice through the tail vein, and the mice were treated for 4 more weeks with CCl4 (total, 8 weeks). Sirius red and GFP staining clearly indicated migrated BMCs existing along with fibers, with strong expression of matrix metalloproteinase (MMP)–9 shown by anti-MMP–9 antibodies and in situ hybridization. Double fluorescent immunohistochemistry showed the expression of MMP–9 on the GFP–positive cell surface. Film in situ zymographic analysis revealed strong gelatinolytic activity in the periportal area coinciding with the location of MMP–9-positive BMCs. Four weeks after BMC transplantation, mice had significantly reduced liver fibrosis, as assessed by hydroxyproline content of the livers, compared to that of mice treated with CCl4 alone. Subpopulation of Liv8–negative BMCs was responsible for this fibrolytic effect. In conclusion , mice with BMC transplants with continuous CCl4 injection had reduced liver fibrosis and a significantly improved survival rate after BMC transplantation compared with mice treated with CCl4 alone. This finding introduces a new concept for the therapy of liver fibrosis. Supplementary material for this article can be found on the Hepatology website ( http://interscience.wiley.com/jpages/0270–9139/suppmat/index.html ). (Hepatology 2004;40:1304-1311.)

Từ khóa


Tài liệu tham khảo

Petersen, 1999, Bone marrow as a potential source of hepatic oval cells., Science, 284, 1168, 10.1126/science.284.5417.1168

Theise, 2000, Liver from bone marrow in humans., HEPATOLOGY, 32, 11, 10.1053/jhep.2000.9124

Alison, 2000, Hepatocytes from nonhepatic adult stem cells., Nature, 406, 257, 10.1038/35018642

Krause, 2001, Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell., Cell, 105, 369, 10.1016/S0092-8674(01)00328-2

Lagasse, 2000, Purified hematopoietic stem cells can differentiate into hepatocytes in vivo., Nat Med, 6, 1229, 10.1038/81326

Orlic, 2001, Bone marrow cells regenerate infarcted myocardium., Nature, 410, 701, 10.1038/35070587

Korbling, 2002, Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells., N Engl J Med, 346, 738, 10.1056/NEJMoa3461002

Okamoto, 2002, Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract., Nat Med, 8, 1011, 10.1038/nm755

Wagers, 2002, Little evidence for developmental plasticity of adult hematopoietic stem cells., Science, 297, 2256, 10.1126/science.1074807

Okabe, 1997, Green mice as a source of ubiquitous green cells., FEBS Lett, 407, 313, 10.1016/S0014-5793(97)00313-X

Terai, 2003, An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes., J Biochem (Tokyo), 134, 551, 10.1093/jb/mvg173

Yamamoto, 2004, A subpopulation of bone marrow cells depleted by a novel antibody, anti-Liv8, is useful for cell therapy to repair damaged liver., Biochem Biophys Res Commun, 313, 1110, 10.1016/j.bbrc.2003.12.044

Watanabe, 2002, SEK1MKK4-mediated SAPKJNK signaling participates in embryonic hepatoblast proliferation via a pathway different from NF-kappaB-induced anti-apoptosis., Dev Biol, 250, 332, 10.1006/dbio.2002.0781

Sakaida, 1998, Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-beta1 expression in pig serum-induced rat liver fibrosis in vivo., J Hepatol, 28, 471, 10.1016/S0168-8278(98)80322-X

Sakaida, 1999, Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy., Am J Gastroenterol, 94, 489, 10.1111/j.1572-0241.1999.884_m.x

Sakaida, 2003, Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet., J Hepatol, 38, 762, 10.1016/S0168-8278(03)00094-1

Sakaida, 1998, Fibrosis accelerates the development of enzyme-altered lesions in the rat liver., HEPATOLOGY, 28, 1247, 10.1002/hep.510280512

Jimenez, 1999, Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation., Mol Cell Biol, 19, 4431, 10.1128/MCB.19.6.4431

Nakada, 1999, Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors., Am J Pathol, 154, 417, 10.1016/S0002-9440(10)65288-1

Heissig, 2002, Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand., Cell, 109, 625, 10.1016/S0092-8674(02)00754-7

Hattori, 2003, Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1() stem cells from bone-marrow microenvironment., Nat Med, 8, 841, 10.1038/nm740

Tanaka, 1999, Matrix metalloproteinase-9 production, a newly identified function of mast cell progenitors, is downregulated by c-kit receptor activation., Blood, 94, 2390, 10.1182/blood.V94.7.2390.419k16_2390_2395

Baram, 2001, Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha., J Immunol, 167, 4008, 10.4049/jimmunol.167.7.4008

Ohuchi, 1997, Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules., J Biol Chem, 272, 2446, 10.1074/jbc.272.4.2446

Kollet, 2003, HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34 stem cell recruitment to the liver., J Clin Invest, 112, 160, 10.1172/JCI17902

Forbes, 2004, A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis., Gastroenterology, 126, 955, 10.1053/j.gastro.2004.02.025